- Stocks
- Pharma & Healthcare
- TTK Healthcare
TTK Healthcare share price
NSE: TTKHLTCAREPharma & HealthcareDrug Manufacturers - General
TTK Healthcare at a glance
TTK Healthcare (NSE: TTKHLTCARE) closed at ₹994.70 on 22 Oct 2026, up 3.29% on the day. With a market capitalisation of ₹1,406 Cr, it ranks 1300th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - General.
At its last close the stock traded at 21.4× trailing earnings, against a return on equity of 5.9% in FY26. Over the past year the share price has fallen 11.6%. Its 52-week range is ₹735.00 (30 Mar 2026) to ₹1,247.00 (9 Sep 2026); the last close is 20.2% below the high. Promoters held 74.56% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹1,406 CrRank 1300 on NSE
- P/E (trailing)
- 21.4×
- Price to book
- 0.94×FY26
- ROE
- 5.9%FY26
- ROCE
- 8.0%FY26
- Debt to equity
- 0.02FY26
- Net profit margin
- 7.7%FY26
- Book value / share
- ₹785.85FY26
- Dividend payout
- 21.5%FY26
- 52-week high
- ₹1,247.009 Sep 2026
- 52-week low
- ₹735.0030 Mar 2026
- 1-year return
- −11.6%
- RSI (14-day)
- 43
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | +3.29% | −1.5% | −7.0% | −0.8% | −11.6% |
TTK Healthcare financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹476 Cr | ₹599 Cr | ₹725 Cr | ₹753 Cr | ₹801 Cr | ₹857 Cr |
| Operating profit | ₹15 Cr | ₹22 Cr | ₹62 Cr | ₹84 Cr | ₹94 Cr | ₹87 Cr |
| Net profit | ₹46 Cr | ₹42 Cr | ₹640 Cr | ₹63 Cr | ₹82 Cr | ₹66 Cr |
| EPS (₹) | ₹32.87 | ₹29.43 | ₹452.72 | ₹44.47 | ₹57.79 | ₹46.48 |
| Cash from operations | ₹96 Cr | ₹45 Cr | −₹26 Cr | −₹5 Cr | −₹4 Cr | −₹21 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹295 Cr | ₹330 Cr | ₹953 Cr | ₹1,001 Cr | ₹1,065 Cr | ₹1,115 Cr |
TTK Healthcare shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 74.56% | 74.56% | 74.56% | 74.56% | 74.56% | 74.56% |
| Foreign institutions | 1.90% | 1.89% | 1.90% | 1.89% | 1.90% | 1.86% |
| Domestic institutions | 1.14% | 1.18% | 1.18% | 1.08% | 1.11% | 2.19% |
| Non-institutions | 22.40% | 22.37% | 22.36% | 22.46% | 22.43% | 21.39% |
TTK Healthcare vs peers
The listed Pharma & Healthcare companies nearest to TTK Healthcare by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| SURAKSHASuraksha Diagnostic | ₹294.05 | +1.75% | +1.1% | ₹1,531 Cr | 47.6 | — |
| GKSLGujarat Kidney And Super Speciality | ₹183.00 | +0.53% | — | ₹1,443 Cr | 73.5 | — |
| AMRUTANJANAmrutanjan Health Care | ₹496.20 | +0.45% | −29.1% | ₹1,435 Cr | 24.8 | — |
| JAGSNPHARMJagsonpal Ser | ₹216.03 | −1.13% | +2.0% | ₹1,422 Cr | 34.2 | — |
| TTKHLTCARETTK Healthcare | ₹994.70 | +3.29% | −11.6% | ₹1,406 Cr | 21.4 | — |
| FERMENTAFermenta Biotech | ₹466.35 | −0.78% | — | ₹1,373 Cr | — | — |
| KOPRANKopran | ₹274.00 | +3.16% | +64.0% | ₹1,323 Cr | 51.4 | — |
Ask anything about TTK Healthcare
Pivot answers on the live chart with evidence you can check, and tests strategies against TTKHLTCARE's own history. Try: “Why has TTKHLTCARE moved over the last three months?” · “Backtest a 50-day moving-average crossover on TTKHLTCARE over five years” · “Compare TTKHLTCARE with SURAKSHA on margins and valuation”
Frequently asked questions about TTK Healthcare
What is the share price of TTK Healthcare today?
TTK Healthcare (NSE: TTKHLTCARE) last closed at ₹994.70 on 22 Oct 2026. Its 52-week high is ₹1,247.00 and its 52-week low is ₹735.00.
What is the market cap of TTK Healthcare?
TTK Healthcare's market capitalisation is ₹1,406 Cr (₹1,406 Cr) at the 22 Oct 2026 close, ranking 1300th among the NSE companies Pivot tracks.
What is the P/E ratio of TTK Healthcare?
TTK Healthcare trades at a trailing P/E of 21.4. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 47.6.
What is the ROE and ROCE of TTK Healthcare?
Return on equity was 5.9% in FY26 and return on capital employed was 8.0% in FY26 (standalone figures).
Is TTK Healthcare a debt-free company?
TTK Healthcare is close to debt-free: its debt-to-equity ratio was 0.02 in FY26.
How has TTK Healthcare stock performed over the last year?
TTK Healthcare's share price has fallen 11.6% over the past year, −0.8% over three months and −7.0% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of TTK Healthcare?
As of 30 Jun 2026: promoters 74.56%, foreign institutions 1.86%, domestic institutions 2.19%, non-institutions 21.39%.
Who are TTK Healthcare's competitors?
The listed Pharma & Healthcare companies closest to TTK Healthcare by market cap are Suraksha Diagnostic, Gujarat Kidney And Super Speciality, Amrutanjan Health Care, Jagsonpal Ser, Fermenta Biotech and Kopran.
Is TTK Healthcare a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out TTK Healthcare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on TTKHLTCARE against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with T · all NSE stocks · this page as text